Stay updated on Teriparatide vs Denosumab on Bone in Osteoporotic Women Clinical Trial

Sign up to get notified when there's something new on the Teriparatide vs Denosumab on Bone in Osteoporotic Women Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Teriparatide vs Denosumab on Bone in Osteoporotic Women Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the study results or data related to the effects of Teriparatide or Denosumab on bone in postmenopausal women with osteoporosis.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:25.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying that researchers are looking for ambulatory, postmenopausal women with osteoporosis and a bone mineral density (BMD) T-score of at least -2.5. Previously, no information was provided regarding the participation criteria.
    Difference
    27%
    Check dated 2024-05-22T20:52:21.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:17:49.000Z thumbnail image

Stay in the know with updates to Teriparatide vs Denosumab on Bone in Osteoporotic Women Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Teriparatide vs Denosumab on Bone in Osteoporotic Women Clinical Trial page.